Anton Hospach (Toni Hospach, T Hospach)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Juvenile Idiopathic Arthritis

Prognostic Factors

Chronic Kidney Disease

Emergency Department

Top Venues

Rheumatology international

Arthritis & rheumatology (Hoboken, N.J.)

Pediatric rheumatology online journal

ACR open rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Anton Hospach, A Belot, M W Beresford, F Dressler, T Kallinich, Prasad Thomas Oommen, C E Pain, Klaus Tenbrock, F Weller, J Roth, Kirsten Minden, Claas H Hinze, O Sander, C M Hedrich
Letter to the editor re article "The Climate Emergency and the Health of Our Patients: The Role of the Rheumatologist" January 2023. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Angela Zimmer, Ariane Klein, Jasmin Beate Kuemmerle-Deschner, Frank Dressler, Nils Onken, Normi Brueck, Maria Fasshauer, Anton Hospach, Markus Hufnagel, Dirk Foell, Gerd Horneff
Incident psoriasis under treatment with tumor necrosis factor-α inhibitors in juvenile idiopathic arthritis patients-analysis of the BiKeR registry. Rheumatology international (2023)
Franz Thiele, Ariane Klein, Anton Hospach, Daniel Windschall, Sonja Mrusek, J Michael Ruehlmann, Gerd Horneff
Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study. ACR open rheumatology 3 (11) (2021)
Franz Thiele, Ariane Klein, Daniel Windschall, Anton Hospach, Ivan Foeldvari, Kirsten Minden, Frank Weller-Heinemann, Gerd Horneff
Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatology international 41 (4) (2021)
Anton Hospach, Fabian Glowatzki, Friederike Blankenburg, Dennis Conzelmann, Christian Stirnkorb, Chris Sandra Müllerschön, Peter von den Driesch, Lisa Maria Köhler, Meino Rohlfs, Christoph Klein, Fabian Hauck
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents. Pediatric rheumatology online journal 17 (1) (2019)